4-(n,n-dimethylaminosulphonyl)-7-(1-piperazinyl)-2,1,3-benzoxadiazole profile

4-(N,N-dimethylaminosulphonyl)-7-(1-piperazinyl)-2,1,3-benzoxadiazole: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID Source	ID
PubMed CID	132229
SCHEMBL ID	14778790
MeSH ID	M0206335

Synonyms (23)

Synonym
4-benzofurazansulfonamide, n,n-dimethyl-7-(1-piperazinyl)-
7-(1-piperazinyl)-n,n-dimethyl-4-benzofurazan sulfonamide
4-(n,n-dimethylaminosulphonyl)-7-(1-piperazinyl)-2,1,3-benzoxadiazole
dbd-pz
139332-64-2
4-(n,n-dimethylaminosulfonyl)-7-piperazinobenzofurazan
4-(n,n-dimethylaminosulfonyl)-7-piperazino-2,1,3-benzoxadiazole
n,n-dimethyl-7-piperazin-1-yl-2,1,3-benzoxadiazole-4-sulfonamide
4-(n,n-dimethylsulfamoyl)-7-piperazino-benzofurazan
SCHEMBL14778790
DTXSID30161012
4-(n,n-dimethylsulfamoyl)-7-piperazino-benzofurazan, for fluorescence, >=99.0%
AKOS030530734
n,n-dimethyl-7-(piperazin-1-yl)-2,1,3-benzoxadiazole-4-sulfonamide
mfcd00191375
AS-72212
J-007265
dbd-pz [=4-(n,n-dimethylaminosulfonyl)-7-piperazino-2,1,3-benzoxadiazole] [for hplc labeling]
n,n-dimethyl-7-(piperazin-1-yl)benzo[c][1,2,5]oxadiazole-4-sulfonamide
D95250
2,1,3-benzoxadiazole-4-sulfonamide, n,n-dimethyl-7-(1-piperazinyl)-
dimethylaminosulfonylpiperazinobezoxadiazol
CS-0328802

Research

Studies (7)

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	0 (0.00)	18.7374
1990's	3 (42.86)	18.2507
2000's	2 (28.57)	29.6817
2010's	2 (28.57)	24.3611
2020's	0 (0.00)	2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.25

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

Metric	This Compound (vs All)
Research Demand Index	12.25 (24.57)
Research Supply Index	2.20 (2.92)
Research Growth Index	4.45 (4.65)
Search Engine Demand Index	0.00 (26.88)
Search Engine Supply Index	0.00 (0.95)

This Compound (12.25)

All Compounds (24.57)

Study Types

Publication Type	This drug (%)	All Drugs (%)
Trials	0 (0.00%)	5.53%
Reviews	0 (0.00%)	6.00%
Case Studies	0 (0.00%)	4.05%
Observational	0 (0.00%)	0.25%
Other	8 (100.00%)	84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Substance	Relationship Strength	Studies	Classes	Roles
lactic acid Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed). 2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.	2	1	2-hydroxy monocarboxylic acid	algal metabolite; Daphnia magna metabolite
4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride: structure in first source	2.11	1
hsr 609 HSR 609: structure in first source	1.99	1
oxadiazoles Oxadiazoles: Compounds containing five-membered heteroaromatic rings containing two carbons, two nitrogens, and one oxygen atom which exist in various regioisomeric forms.	3.41	7
cellulose DEAE-Cellulose: Cellulose derivative used in chromatography, as ion-exchange material, and for various industrial applications.	2	1	glycoside

Condition	Indicated	Relationship Strength	Studies	Trials
Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)	0	1.99	1	0

4-(n,n-dimethylaminosulphonyl)-7-(1-piperazinyl)-2,1,3-benzoxadiazole

Description